Membrane assembly of Shiga toxin glycosphingolipid receptors and toxin refractiveness of MDCK II epithelial cells[S]
暂无分享,去创建一个
A. Mellmann | H. Karch | G. Pohlentz | Ivan U. Kouzel | I. Liashkovich | J. Müthing | Daniel Steil | N. Legros
[1] J. Shillcock,et al. Clustering on Membranes: Fluctuations and More. , 2018, Trends in cell biology.
[2] H. Karch,et al. Shiga Toxin Glycosphingolipid Receptors in Human Caco-2 and HCT-8 Colon Epithelial Cell Lines , 2017, Toxins.
[3] L. Johannes. Shiga Toxin—A Model for Glycolipid-Dependent and Lectin-Driven Endocytosis , 2017, Toxins.
[4] H. Karch,et al. Colocalization of receptors for Shiga toxins with lipid rafts in primary human renal glomerular endothelial cells and influence of D-PDMP on synthesis and distribution of glycosphingolipid receptors , 2017, Glycobiology.
[5] T. Fujiwara,et al. Development of new ganglioside probes and unraveling of raft domain structure by single-molecule imaging. , 2017, Biochimica et biophysica acta. General subjects.
[6] H. Gröne,et al. Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells , 2017, Front. Immunol..
[7] H. Gröne,et al. Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals[S] , 2017, Journal of Lipid Research.
[8] Alicia Llorente,et al. Lipids in exosomes: Current knowledge and the way forward. , 2017, Progress in lipid research.
[9] K. Sandvig,et al. Protection against Shiga Toxins , 2017, Toxins.
[10] Jürgen Kopitz,et al. Lipid glycosylation: a primer for histochemists and cell biologists , 2017, Histochemistry and Cell Biology.
[11] J. Shillcock,et al. Mechanism of Shiga Toxin Clustering on Membranes , 2016, ACS nano.
[12] L. Johannes,et al. Glycolipids and Lectins in Endocytic Uptake Processes. , 2016, Journal of molecular biology.
[13] B. Kemper,et al. Shiga toxin of enterohaemorrhagic Escherichia coli directly injures developing human erythrocytes , 2016, Cellular microbiology.
[14] C. Silberstein,et al. Effects of shiga toxin 2 on cellular regeneration mechanisms in primary and three-dimensional cultures of human renal tubular epithelial cells. , 2016, Microbial pathogenesis.
[15] G. D’Angelo,et al. Glycosphingolipid–Protein Interaction in Signal Transduction , 2016, International journal of molecular sciences.
[16] H. Khandelia,et al. Membrane invagination induced by Shiga toxin B-subunit: from molecular structure to tube formation. , 2016, Soft matter.
[17] V. L. Tesh,et al. Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applications , 2016, Toxins.
[18] H. Karch,et al. Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment1[S] , 2015, Journal of Lipid Research.
[19] C. Ibarra,et al. Prevention of renal damage caused by Shiga toxin type 2: Action of Miglustat on human endothelial and epithelial cells. , 2015, Toxicon : official journal of the International Society on Toxinology.
[20] W. Römer,et al. Plasma membrane reorganization: A glycolipid gateway for microbes. , 2015, Biochimica et biophysica acta.
[21] J. Shillcock,et al. The effects of globotriaosylceramide tail saturation level on bilayer phases. , 2015, Soft matter.
[22] S. Teneberg,et al. Porcine intestinal glycosphingolipids recognized by F6-fimbriated enterotoxigenic Escherichia coli. , 2014, Microbial pathogenesis.
[23] J. Terajima,et al. Shiga Toxin (Verotoxin)-Producing Escherichia coli in Japan , 2014, Microbiology spectrum.
[24] L. Johannes,et al. Carbohydrate conformation and lipid condensation in monolayers containing glycosphingolipid Gb3: influence of acyl chain structure. , 2014, Biophysical journal.
[25] P. Tarr,et al. Shiga Toxin/Verocytotoxin-Producing Escherichia coli Infections: Practical Clinical Perspectives , 2014, Microbiology spectrum.
[26] N. Gretz,et al. Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure , 2014, The Journal of pathology.
[27] D. Werz,et al. Influence of Gb3 glycosphingolipids differing in their fatty acid chain on the phase behaviour of solid supported membranes: chemical syntheses and impact of Shiga toxin binding , 2014 .
[28] K. Gaus,et al. The organisation of the cell membrane: do proteins rule lipids? , 2014, Current opinion in chemical biology.
[29] K. Sandvig,et al. Lipid requirements for entry of protein toxins into cells. , 2014, Progress in lipid research.
[30] P. Insel,et al. Interaction of membrane/lipid rafts with the cytoskeleton: impact on signaling and function: membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling. , 2014, Biochimica et biophysica acta.
[31] H. Karch,et al. Progress in detection and structural characterization of glycosphingolipids in crude lipid extracts by enzymatic phospholipid disintegration combined with thin-layer chromatography immunodetection and IR-MALDI mass spectrometry. , 2014, Analytical chemistry.
[32] P. Marsden,et al. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome , 2013, Virulence.
[33] H. Gröne,et al. Cell-specific in vivo functions of glycosphingolipids: lessons from genetic deletions of enzymes involved in glycosphingolipid synthesis. , 2013, Progress in lipid research.
[34] H. Karch,et al. Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells[S] , 2013, Journal of Lipid Research.
[35] G. Schütz,et al. A critical survey of methods to detect plasma membrane rafts , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.
[36] P. Tazzari,et al. Shiga Toxin 1, as DNA Repair Inhibitor, Synergistically Potentiates the Activity of the Anticancer Drug, Mafosfamide, on Raji Cells , 2013, Toxins.
[37] B. Kemper,et al. Facing glycosphingolipid–Shiga toxin interaction: dire straits for endothelial cells of the human vasculature , 2013, Cellular and Molecular Life Sciences.
[38] S. Sonnino,et al. Membrane domains and the "lipid raft" concept. , 2012, Current medicinal chemistry.
[39] Mary K. Lewinski,et al. Renal and neurological involvement in typical Shiga toxin-associated HUS , 2012, Nature Reviews Nephrology.
[40] Miguel Vicente,et al. The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak , 2012, EMBO molecular medicine.
[41] H. Karch,et al. Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation , 2012, Biological chemistry.
[42] L. Beutin,et al. Multicenter Evaluation of a Sequence-Based Protocol for Subtyping Shiga Toxins and Standardizing Stx Nomenclature , 2012, Journal of Clinical Microbiology.
[43] A. Friedrich,et al. Promiscuous Shiga toxin 2e and its intimate relationship to Forssman. , 2012, Glycobiology.
[44] W. Lencer,et al. Insights on the trafficking and retro-translocation of glycosphingolipid-binding bacterial toxins , 2012, Front. Cell. Inf. Microbio..
[45] A. Friedrich,et al. Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells , 2012, Biological chemistry.
[46] D. Motto. Endothelial cells and thrombotic microangiopathy. , 2012, Seminars in nephrology.
[47] A. Shevchenko,et al. Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane , 2012, The Journal of cell biology.
[48] V. L. Tesh,et al. Activation of cell stress response pathways by Shiga toxins , 2012, Cellular microbiology.
[49] J. Dukes,et al. The MDCK variety pack: choosing the right strain , 2011, BMC Cell Biology.
[50] P. Hsueh,et al. European Escherichia coli O104:H4 outbreak. , 2011, Journal of the Formosan Medical Association = Taiwan yi zhi.
[51] Alfred H. Merrill,et al. Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics , 2011, Chemical reviews.
[52] T. Kolter. A view on sphingolipids and disease. , 2011, Chemistry and physics of lipids.
[53] A. Mellmann,et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. , 2011, The Lancet. Infectious diseases.
[54] Ari Helenius,et al. Lipid-mediated endocytosis. , 2011, Cold Spring Harbor perspectives in biology.
[55] D. Leyva-Illades,et al. Differential Response of the Human Renal Proximal Tubular Epithelial Cell Line HK-2 to Shiga Toxin Types 1 and 2 , 2011, Infection and Immunity.
[56] D. Lingwood,et al. Cholesterol modulates glycolipid conformation and receptor activity. , 2011, Nature chemical biology.
[57] A. Friedrich,et al. Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains[S] , 2011, Journal of Lipid Research.
[58] A. Warley,et al. Isolation of nano–meso scale detergent resistant membrane that has properties expected of lipid ‘rafts’ , 2011, Journal of neurochemistry.
[59] K. Sandvig,et al. Endocytosis and retrograde transport of Shiga toxin. , 2010, Toxicon : official journal of the International Society on Toxinology.
[60] G. Bally,et al. Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells , 2010, Thrombosis and Haemostasis.
[61] M. Gerl,et al. Revitalizing membrane rafts: new tools and insights , 2010, Nature Reviews Molecular Cell Biology.
[62] T. Niki,et al. Galectin-9 trafficking regulates apical-basal polarity in Madin–Darby canine kidney epithelial cells , 2010, Proceedings of the National Academy of Sciences.
[63] C. Ackerley,et al. A Major Fraction of Glycosphingolipids in Model and Cellular Cholesterol-containing Membranes Is Undetectable by Their Binding Proteins* , 2010, The Journal of Biological Chemistry.
[64] A. Friedrich,et al. On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[65] A. Friedrich,et al. Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors[S] , 2010, Journal of Lipid Research.
[66] Perttu S. Niemelä,et al. Membrane proteins diffuse as dynamic complexes with lipids. , 2010, Journal of the American Chemical Society.
[67] A. Surolia,et al. Glycosphingolipids in microdomain formation and their spatial organization , 2010, FEBS Letters.
[68] B. Binnington,et al. Globotriaosyl ceramide receptor function – Where membrane structure and pathology intersect , 2010, FEBS letters.
[69] J. Müthing,et al. Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. , 2010, Mass spectrometry reviews.
[70] M. Morigi,et al. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction , 2010, Pediatric Nephrology.
[71] L. Johannes,et al. Shiga toxins — from cell biology to biomedical applications , 2010, Nature Reviews Microbiology.
[72] Kai Simons,et al. Lipid Rafts As a Membrane-Organizing Principle , 2010, Science.
[73] Jens Soltwisch,et al. Structural profiling of individual glycosphingolipids in a single thin-layer chromatogram by multiple sequential immunodetection matched with Direct IR-MALDI-o-TOF mass spectrometry. , 2009, Analytical chemistry.
[74] D. Lingwood,et al. Order of lipid phases in model and plasma membranes , 2009, Proceedings of the National Academy of Sciences.
[75] A. Friedrich,et al. Shiga Toxin Receptor Gb3Cer/CD77: Tumor-Association and Promising Therapeutic Target in Pancreas and Colon Cancer , 2009, PloS one.
[76] L. Johannes,et al. Lipid Reorganization Induced by Shiga Toxin Clustering on Planar Membranes , 2009, PloS one.
[77] C. Lingwood,et al. Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. , 2009, Kidney international.
[78] L. Pike. The challenge of lipid rafts This work was supported by National Institutes of Health grants RO1 GM064491 and R01 GM082824 to LJP. Published, JLR Papers in Press, October 27, 2008. , 2009, Journal of Lipid Research.
[79] S. Hell,et al. Direct observation of the nanoscale dynamics of membrane lipids in a living cell , 2009, Nature.
[80] A. Friedrich,et al. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury , 2009, Thrombosis and Haemostasis.
[81] R. Iglesias-Bartolome,et al. Complex gangliosides are apically sorted in polarized MDCK cells and internalized by clathrin‐independent endocytosis , 2008, The FEBS journal.
[82] J. Zimmerberg,et al. Progressive ordering with decreasing temperature of the phospholipids of influenza virus. , 2008, Nature chemical biology.
[83] A. Friedrich,et al. Matching IR-MALDI-o-TOF mass spectrometry with the TLC overlay binding assay and its clinical application for tracing tumor-associated glycosphingolipids in hepatocellular and pancreatic cancer. , 2008, Analytical chemistry.
[84] A. Friedrich,et al. Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity , 2008, Glycoconjugate Journal.
[85] Katharina Gaus,et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells , 2007, Nature.
[86] D. Lingwood,et al. Detergent resistance as a tool in membrane research , 2007, Nature Protocols.
[87] N. Roche,et al. Human gastric glycosphingolipids recognized by Helicobacter pylori vacuolating cytotoxin VacA. , 2007, Microbes and infection.
[88] Deborah A. Brown,et al. Lipid rafts, detergent-resistant membranes, and raft targeting signals. , 2006, Physiology.
[89] S. Sonnino,et al. Dynamic and Structural Properties of Sphingolipids as Driving Forces for the Formation of Membrane Domains , 2006 .
[90] Sandro Sonnino,et al. Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. , 2006, Chemical reviews.
[91] W. Lencer,et al. Raft trafficking of AB5 subunit bacterial toxins. , 2005, Biochimica et biophysica acta.
[92] A. Friedrich,et al. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. , 2005, Rapid communications in mass spectrometry : RCM.
[93] H. Karch,et al. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium , 2005, Thrombosis and Haemostasis.
[94] P. Tarr,et al. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.
[95] L. Johannes,et al. Glycosphingolipids as toxin receptors. , 2004, Seminars in cell & developmental biology.
[96] N. Kiyokawa,et al. Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells , 2004, Journal of Cell Science.
[97] D. Lingwood,et al. Effect of Globotriaosyl Ceramide Fatty Acid α-Hydroxylation on the Binding by Verotoxin 1 and Verotoxin 2 , 2002, Neurochemical Research.
[98] L. Barbieri,et al. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells 1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[99] D. Brown,et al. Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). , 2000, Biochimica et biophysica acta.
[100] S. Sonnino,et al. Evidence that ganglioside enriched domains are distinct from caveolae in MDCK II and human fibroblast cells in culture. , 2000, European journal of biochemistry.
[101] P. Stricklett,et al. Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. , 2000, Kidney international.
[102] C. Lingwood,et al. Retroviral Transfection of Madin-Darby Canine Kidney Cells with Human MDR1 Results in a Major Increase in Globotriaosylceramide and 105- to 106-Fold Increased Cell Sensitivity to Verocytotoxin , 2000, The Journal of Biological Chemistry.
[103] M.Alan Chester,et al. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids--recommendations 1997. , 1998, European journal of biochemistry.
[104] J. Müthing,et al. Nanogram detection of phospholipids on thin-layer chromatograms. , 1998, Analytical biochemistry.
[105] E. Ikonen,et al. Functional rafts in cell membranes , 1997, Nature.
[106] G. van Meer,et al. Sorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells , 1996, The Journal of cell biology.
[107] D. Brown,et al. Characterization of proteins in detergent-resistant membrane complexes from Madin-Darby canine kidney epithelial cells. , 1995, Biochemistry.
[108] G. van Meer,et al. Differential targeting of glucosylceramide and galactosylceramide analogues after synthesis but not during transcytosis in Madin-Darby canine kidney cells , 1995, The Journal of cell biology.
[109] C. Zurzolo,et al. VIP21/caveolin, glycosphingolipid clusters and the sorting of glycosylphosphatidylinositol‐anchored proteins in epithelial cells. , 1994, The EMBO journal.
[110] M. Lisanti,et al. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells , 1993, The Journal of cell biology.
[111] K. Simons,et al. Glycosphingolipid-enriched, detergent-insoluble complexes in protein sorting in epithelial cells. , 1993, Biochemistry.
[112] K. Sandvig,et al. Entry of protein toxins in polarized epithelial cells. , 1993, Cancer research.
[113] Deborah A. Brown,et al. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.
[114] A. Sonnenberg,et al. Apical and basal Forssman antigen in MDCK II cells: a morphological and quantitative study. , 1991, European journal of cell biology.
[115] B. Deurs,et al. Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells , 1991, The Journal of cell biology.
[116] C. Lingwood,et al. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. , 1987, The Journal of biological chemistry.
[117] P. Mühlradt,et al. Forssman glycolipid, an antigenic marker for a major subpopulation of macrophages from murine spleen and peripheral lymph nodes. , 1987, Journal of immunology.
[118] H. Egge,et al. Structural characterization of gangliosides from murine T lymphocytes. , 1987, European journal of biochemistry.
[119] J. Sanders,et al. Isolation and characterization of two types of MDCK epithelial cell clones based on glycosphingolipid pattern. , 1986, Biochimica et biophysica acta.
[120] P. Mühlradt,et al. An improved semi-quantitative enzyme immunostaining procedure for glycosphingolipid antigens on high performance thin layer chromatograms. , 1986, Journal of immunological methods.
[121] G. Meer,et al. Two strains of the Madin‐Darby canine kidney (MDCK) cell line have distinct glycosphingolipid compositions. , 1986, The EMBO journal.
[122] Portland Press Ltd. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and symbolism for amino acids and peptides. Recommendations 1983. , 1984, European journal of biochemistry.
[123] T. Saito,et al. Quantitative isolation of total glycosphingolipids from animal cells. , 1971, Journal of lipid research.
[124] C. Frey,et al. Manganous chloride spray reagent for cholesterol and bile acids on thin-layer chromatograms. , 1970, Journal of chromatography.
[125] E. L. Kean. Separation of gluco- and galactocerebrosides by means of borate thin-layer chromatography. , 1966, Journal of lipid research.
[126] H. Karch,et al. Shiga toxin glycosphingolipid receptors and their lipid membrane ensemble in primary human blood–brain barrier endothelial cells , 2017, Glycobiology.
[127] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[128] L. Teel,et al. Pathogenesis of Shiga-toxin producing escherichia coli. , 2012, Current topics in microbiology and immunology.
[129] K. Sandvig,et al. Shiga toxins. , 2012, Toxicon : official journal of the International Society on Toxinology.
[130] C. Lingwood. Glycosphingolipid functions. , 2011, Cold Spring Harbor perspectives in biology.
[131] S. Levery. Glycosphingolipid structural analysis and glycosphingolipidomics. , 2005, Methods in enzymology.
[132] M. Bomsel,et al. Entry of viruses through the epithelial barrier: pathogenic trickery , 2003, Nature Reviews Molecular Cell Biology.
[133] J. Müthing. TLC in structure and recognition studies of glycosphingolipids. , 1998, Methods in molecular biology.
[134] K. Karlsson. Animal glycosphingolipids as membrane attachment sites for bacteria. , 1989, Annual review of biochemistry.
[135] R. Yu,et al. Gangliosides: structure, isolation, and analysis. , 1982, Methods in enzymology.
[136] J. Dittmer,et al. A SIMPLE, SPECIFIC SPRAY FOR THE DETECTION OF PHOSPHOLIPIDS ON THIN-LAYER CHROMATOGRAMS. , 1964, Journal of lipid research.